These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28984791)

  • 1. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis.
    Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M
    Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
    Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
    Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The long coding RNA GSTM3TV2 acts an oncogene to promote chemoresistance in pancreatic cancer].
    Xiong GB; Yang G; Feng MY; Zhao FY; Zheng LF; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):691-697. PubMed ID: 31474062
    [No Abstract]   [Full Text] [Related]  

  • 5. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
    Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
    Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
    Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
    Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
    Liang C; Fukuda T; Isaji T; Duan C; Song W; Wang Y; Gu J
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129870. PubMed ID: 33571582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
    Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
    Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer.
    Lerbs T; Bisht S; Schölch S; Pecqueux M; Kristiansen G; Schneider M; Hofmann BT; Welsch T; Reissfelder C; Rahbari NN; Fritzmann J; Brossart P; Weitz J; Feldmann G; Kahlert C
    BMC Cancer; 2017 Apr; 17(1):249. PubMed ID: 28388884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
    Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S
    Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
    Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
    J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Therapeutic Potential of SOX9 in Chordoma.
    Chen H; Garbutt CC; Spentzos D; Choy E; Hornicek FJ; Duan Z
    Clin Cancer Res; 2017 Sep; 23(17):5176-5186. PubMed ID: 28606919
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
    Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
    Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
    Masuo K; Chen R; Yogo A; Sugiyama A; Fukuda A; Masui T; Uemoto S; Seno H; Takaishi S
    Cancer Sci; 2021 Dec; 112(12):4987-4999. PubMed ID: 34628696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
    Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
    Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells.
    Yin T; Wei H; Leng Z; Yang Z; Gou S; Wu H; Zhao G; Hu X; Wang C
    Chemotherapy; 2011; 57(6):488-96. PubMed ID: 22248802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.
    Zhao G; Cui J; Zhang JG; Qin Q; Chen Q; Yin T; Deng SC; Liu Y; Liu L; Wang B; Tian K; Wang GB; Wang CY
    Gene Ther; 2011 Sep; 18(9):920-8. PubMed ID: 21677689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.